In addition, through serological proteome analysis (SERPA), anti-ALDOA antibodies were detected in about 30% of PDA patients and, in a fraction of them, the GEM-based treatment further increased antibody titer [10]. Here, ALDOA is linked to Patent ductus arteriosus.